332 related articles for article (PubMed ID: 27603293)
21. Prospective long-term outcomes of a cohort of Ugandan children with laboratory monitoring during antiretroviral therapy.
Kekitiinwa A; Asiimwe AR; Kasirye P; Korutaro V; Kitaka S; Maganda A; Madalon M; Graziano FM
Pediatr Infect Dis J; 2012 Aug; 31(8):e117-25. PubMed ID: 22581223
[TBL] [Abstract][Full Text] [Related]
22. No change in viral set point or CD4 cell decline among antiretroviral treatment-naïve, HIV-1-infected individuals enrolled in the Danish HIV Cohort Study in 1995-2010.
Helleberg M; Kronborg G; Larsen CS; Pedersen G; Pedersen C; Obel N; Gerstoft J
HIV Med; 2013 Jul; 14(6):362-9. PubMed ID: 23433434
[TBL] [Abstract][Full Text] [Related]
23. A trial of three antiretroviral regimens in HIV-1-infected children.
Luzuriaga K; McManus M; Mofenson L; Britto P; Graham B; Sullivan JL;
N Engl J Med; 2004 Jun; 350(24):2471-80. PubMed ID: 15190139
[TBL] [Abstract][Full Text] [Related]
24. Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy.
Scherpenisse M; Kootstra NA; Bakker M; Berkhout B; Pasternak AO
mBio; 2021 Mar; 12(2):. PubMed ID: 33688002
[TBL] [Abstract][Full Text] [Related]
25. Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships.
Mujugira A; Celum C; Tappero JW; Ronald A; Mugo N; Baeten JM
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):148-54. PubMed ID: 26670218
[TBL] [Abstract][Full Text] [Related]
26. Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda.
Tukei VJ; Murungi M; Asiimwe AR; Migisha D; Maganda A; Bakeera-Kitaka S; Kalyesubula I; Musoke P; Kekitiinwa A
BMC Pediatr; 2013 Mar; 13():42. PubMed ID: 23536976
[TBL] [Abstract][Full Text] [Related]
27. Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppression.
O'Connor JL; Smith CJ; Lampe FC; Hill T; Gompels M; Hay P; Chadwick D; Fisher M; Ainsworth J; Gilson R; Mackie N; Anderson J; Orkin C; Nelson M; Kegg S; Leen C; Palfreeman A; Post F; Johnson M; Sabin CA; Phillips AN;
AIDS; 2014 Mar; 28(6):919-24. PubMed ID: 24335482
[TBL] [Abstract][Full Text] [Related]
28. Change in absolute CD4 count with antiretroviral treatment in resource limited setting: a retrospective cohort study in children in Ethiopia.
Berhan Y
Ethiop Med J; 2011 Oct; 49(4):289-98. PubMed ID: 23409394
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of acutely HIV-1-infected individuals following rapid antiretroviral therapy initiation.
Girometti N; Nwokolo N; McOwan A; Whitlock G
Antivir Ther; 2017; 22(1):77-80. PubMed ID: 27585954
[TBL] [Abstract][Full Text] [Related]
30. HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration.
Jiamsakul A; Kariminia A; Althoff KN; Cesar C; Cortes CP; Davies MA; Do VC; Eley B; Gill J; Kumarasamy N; Machado DM; Moore R; Prozesky H; Zaniewski E; Law M
J Acquir Immune Defic Syndr; 2017 Nov; 76(3):319-329. PubMed ID: 28708808
[TBL] [Abstract][Full Text] [Related]
31. Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study.
Salazar-Vizcaya L; Keiser O; Karl Technau ; Davies MA; Haas AD; Blaser N; Cox V; Eley B; Rabie H; Moultrie H; Giddy J; Wood R; Egger M; Estill J
AIDS; 2014 Oct; 28(16):2451-60. PubMed ID: 25392857
[TBL] [Abstract][Full Text] [Related]
32. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.
Hocqueloux L; Avettand-Fènoël V; Jacquot S; Prazuck T; Legac E; Mélard A; Niang M; Mille C; Le Moal G; Viard JP; Rouzioux C;
J Antimicrob Chemother; 2013 May; 68(5):1169-78. PubMed ID: 23335199
[TBL] [Abstract][Full Text] [Related]
33. Successful paediatric HIV treatment in rural primary care in Africa.
Janssen N; Ndirangu J; Newell ML; Bland RM
Arch Dis Child; 2010 Jun; 95(6):414-21. PubMed ID: 19880392
[TBL] [Abstract][Full Text] [Related]
34. Virologic Response to Early Antiretroviral Therapy in HIV-infected Infants: Evaluation After 2 Years of Treatment in the Pediacam Study, Cameroon.
Ateba Ndongo F; Texier G; Ida Penda C; Tejiokem MC; Tetang Ndiang S; Ndongo JA; Guemkam G; Sofeu CL; Kfutwah A; Faye A; Msellati P; Warszawski J;
Pediatr Infect Dis J; 2018 Jan; 37(1):78-84. PubMed ID: 28841582
[TBL] [Abstract][Full Text] [Related]
35. Country of birth does not influence long-term clinical, virologic, and immunological outcome of HIV-infected children living in the Netherlands: a cohort study comparing children born in the Netherlands with children born in Sub-Saharan Africa.
Cohen S; van Bilsen WP; Smit C; Fraaij PL; Warris A; Kuijpers TW; Geelen SP; Wolfs TF; Scherpbier HJ; van Rossum AM; Pajkrt D
J Acquir Immune Defic Syndr; 2015 Feb; 68(2):178-85. PubMed ID: 25405830
[TBL] [Abstract][Full Text] [Related]
36. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
[TBL] [Abstract][Full Text] [Related]
37. Efficient monitoring of HIV-1 vertically infected children in Kenya on first-line antiretroviral therapy.
Lihana RW; Lwembe RM; Bi X; Ochieng W; Panikulam A; Palakudy T; Musoke R; Owens M; Ishizaki A; Okoth FA; Songok EM; Ichimura H
J Clin Virol; 2011 Oct; 52(2):123-8. PubMed ID: 21798798
[TBL] [Abstract][Full Text] [Related]
38. Alcohol use and immune reconstitution among HIV-infected patients on antiretroviral therapy in Nairobi, Kenya.
Cagle A; McGrath C; Richardson BA; Donovan D; Sakr S; Yatich N; Ngomoa R; Chepngeno Langat A; John-Stewart G; Chung MH
AIDS Care; 2017 Sep; 29(9):1192-1197. PubMed ID: 28132519
[TBL] [Abstract][Full Text] [Related]
39. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.
Cillo AR; Hilldorfer BB; Lalama CM; McKinnon JE; Coombs RW; Tenorio AR; Fox L; Gandhi RT; Ribaudo H; Currier JS; Gulick RM; Wilkin TJ; Mellors JW
AIDS; 2015 Oct; 29(16):2121-9. PubMed ID: 26544577
[TBL] [Abstract][Full Text] [Related]
40. Frequency of Viremic Episodes in HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy: A Cohort Study.
Myer L; Dunning L; Lesosky M; Hsiao NY; Phillips T; Petro G; Zerbe A; McIntyre JA; Abrams EJ
Clin Infect Dis; 2017 Feb; 64(4):422-427. PubMed ID: 27927852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
